These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4984765)

  • 1. In vitro activity of coumermycin A1 against Mycobacterium tuberculosis var. hominis.
    Duma RJ; Warner JF
    Appl Microbiol; 1969 Sep; 18(3):404-5. PubMed ID: 4984765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bactericidal activities of the pyrrole derivative BM212 against multidrug-resistant and intramacrophagic Mycobacterium tuberculosis strains.
    Deidda D; Lampis G; Fioravanti R; Biava M; Porretta GC; Zanetti S; Pompei R
    Antimicrob Agents Chemother; 1998 Nov; 42(11):3035-7. PubMed ID: 9797251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A regio- and stereoselective 1,3-dipolar cycloaddition for the synthesis of new-fangled dispiropyrrolothiazoles as antimycobacterial agents.
    Almansour AI; Ali S; Ali MA; Ismail R; Choon TS; Sellappan V; Elumalai KK; Pandian S
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7418-21. PubMed ID: 23122863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrrolnitrin and related pyrroles endowed with antibacterial activities against Mycobacterium tuberculosis.
    Di Santo R; Costi R; Artico M; Massa S; Lampis G; Deidda D; Pompei R
    Bioorg Med Chem Lett; 1998 Oct; 8(20):2931-6. PubMed ID: 9873650
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Ruiz P; Causse M; Vaquero M; Casal M
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro evaluation of the antibacterial activity of nemonoxacin against
    Jiang GL; Wang F; Xue Y; Jia JN; Huang HR
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Dec; 43(12):1061-1065. PubMed ID: 33333640
    [No Abstract]   [Full Text] [Related]  

  • 7. Diversity oriented design of various hydrazides and their in vitro evaluation against Mycobacterium tuberculosis H37Rv strains.
    Manvar A; Bavishi A; Radadiya A; Patel J; Vora V; Dodia N; Rawal K; Shah A
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4728-31. PubMed ID: 21752642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BM 212 and its derivatives as a new class of antimycobacterial active agents.
    Biava M
    Curr Med Chem; 2002 Nov; 9(21):1859-69. PubMed ID: 12369872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of linezolid against multidrug-resistant Mycobacterium tuberculosis isolates.
    Erturan Z; Uzun M
    Int J Antimicrob Agents; 2005 Jul; 26(1):78-80. PubMed ID: 15950439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and anti-mycobacterial activity of 1,2,3,5-tetrasubstituted pyrrolyl-N-acetic acid derivatives.
    Pagadala LR; Mukkara LD; Singireddi S; Singh A; Thummaluru VR; Jagarlamudi PS; Guttala RS; Perumal Y; Dharmarajan S; Upadhyayula SM; Ummanni R; Basireddy VS; Ravirala N
    Eur J Med Chem; 2014 Sep; 84():118-26. PubMed ID: 25016370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro activity of fluorinated quinolones and macrolides against drug-resistant Mycobacterium tuberculosis.
    Hoffner SE; Gezelius L; Olsson-Liljequist B
    J Antimicrob Chemother; 1997 Dec; 40(6):885-8. PubMed ID: 9462443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibilities of Mycobacterium tuberculosis to 10 antimicrobial agents.
    Byrne SK; Crawford CE; Geddes GL; Black WA
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1441-2. PubMed ID: 3143305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of ciprofloxacin and ofloxacin against the Mycobacterium avium-intracellulare complex.
    Johnson SM; Roberts GD
    Diagn Microbiol Infect Dis; 1987 May; 7(1):89-91. PubMed ID: 3121243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiological and pharmacological evaluation of BL-C 43, a new semisynthetic derivative of coumermycin A1.
    Price KE; Chisholm DR; Leitner F; Misiek M
    Antimicrob Agents Chemother (Bethesda); 1969; 9():209-18. PubMed ID: 5396489
    [No Abstract]   [Full Text] [Related]  

  • 15. Spectra of susceptibility of Neisseria meningitidis to antimicrobial agents in vitro.
    Devine LF; Hagerman CR
    Appl Microbiol; 1970 Feb; 19(2):329-34. PubMed ID: 4985432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare.
    Fenlon CH; Cynamon MH
    Antimicrob Agents Chemother; 1986 Mar; 29(3):386-8. PubMed ID: 2940969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro activity of six fluorinated quinolones against Mycobacterium tuberculosis.
    Berlin OG; Young LS; Bruckner DA
    J Antimicrob Chemother; 1987 May; 19(5):611-5. PubMed ID: 3112095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of target based novel pyrrolyl phenoxy derivatives as antimycobacterial agents: an in silico approach.
    More UA; Joshi SD; Aminabhavi TM; Kulkarni VH; Badiger AM; Lherbet C
    Eur J Med Chem; 2015 Apr; 94():317-39. PubMed ID: 25771110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of Mycobacterium tuberculosis to ofloxacin and ciprofloxacin in combination with rifampin and isoniazid.
    Casal M; Gutierrez J; González J; Ruiz P
    Chemioterapia; 1987 Dec; 6(6):437-9. PubMed ID: 3124964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The susceptibility of Mycobacterium tuberculosis and atypical mycobacteria in northern Israel.
    Cahana Z; Gabbay R; Raz R
    Drugs; 1995; 49 Suppl 2():171-2. PubMed ID: 8549291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.